Results 61 to 70 of about 1,393 (127)
Navigating social determinants of health barriers in the management of phenylketonuria
Phenylketonuria (PKU) is an inborn error of amino acid metabolism that is typically identified by newborn screening. With lifelong treatment consisting of dietary management, frequent laboratory monitoring, and regular metabolic clinic visits, patients ...
Ashley Andrews, Kate McMinimee
doaj +1 more source
Phenylketonuria in Brazil: a narrative review on treatment and public policies regarding patient and family demands [PDF]
Phenylketonuria (PKU) is an autosomal recessive disorder that affects phenylalanine metabolism and, if left untreated, leads to severe intellectual disability, behavioral problems, cognitive impairments, and other dysfunctions. This study aimed to assess
Daniele Cristina da Silva Napoli +2 more
doaj +2 more sources
Changing dietary practices in phenylketonuria
In recent years, there has been much focus on research on non-dietary treatments in phenylketonuria (PKU). However, diet is likely to remain the major treatment for many years to come, since it has continued to be developed and consistent ...
Anita Macdonald +2 more
doaj
Atherosclerosis and ensuing cardiovascular disease are major causes of death with insufficient treatment options. In search for pathomechanisms of atherosclerosis, we investigated the impact of the B2 bradykinin receptor, Bdkrb2, on atherosclerotic ...
Alexander Perhal +6 more
doaj +1 more source
BackgroundPhenylketonuria (PKU) is due to a defective hepatic enzyme, phenylalanine (Phe) hydroxylase. Transport of the precursor amino acids from blood into the brain for serotonin and dopamine synthesis is reported to be inhibited by high blood Phe ...
Shoji Yano +3 more
doaj +1 more source
Tyrosinase, a copper-containing oxidase, plays a vital role in the melanin biosynthesis pathway. Mutations in the tyrosinase gene can disrupt the hydroxylation of tyrosine, leading to decreased production of 3,4-dihydroxyphenylalanine (DOPA ...
Wei Fan +5 more
doaj +1 more source
Genotype characterization of tetrahydrobiopterin deficiency in two Tibetan children
Background: Tetrahydrobiopterin (BH4) deficiency is a rare cause of hyperphenylalaninemia (HPA). The incidence of this condition varies based on region and ethnicity.
Shuyao Zhu +13 more
doaj +1 more source
P025: Sapropterin therapy in DHPR deficiency: Overcoming barriers in the treatment
Charles Lourenco +5 more
doaj +1 more source
Background: Inherited phenylalanine hydroxylase deficiency, also known as phenylketonuria (PKU), causes poor growth and neurologic deficits in the untreated state.
Jariya Upadia +8 more
doaj +1 more source
Protein and Micronutrient Intake After Two Years of Sapropterin Treatment in PKU. [PDF]
Yilmaz Nas O +7 more
europepmc +1 more source

